Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma
Clinical trial NCT00082836 · COMPLETED
Trial details
- NCT number
- NCT00082836
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.